As only a maximum 30.5% reduction in MDM4 promoter activity was observed following 4 μM XI-006 treatment (Fig. 2), our findings suggest that XI-006 cytotoxicity in Ewing sarcoma cell lines cannot be attributed to repression of MDM4 activity. The gene discussed is MDM4; the disease is Ewing sarcoma.